MedWatch

GN announces US launch of hybrid hearing aid built for OTC sales

GN Hearing has unveiled its launch plans for its hybrid product, Jabra Enhance Plus, which was delayed from last year’s original launch date.

Photo: GN Store Nord / PR

On Tuesday, GN Hearing announces the launch of its hybrid product, Jabra Enhance Plus, originally meant to be on shelves in the second half of last year.

However, the planned launched was delayed due to letdowns in the hearing aid manufacturer’s research and development unit – which was one of the reasons that GN Hearing also had to downgrade its guidance in the beginning of October last year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs